Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

166 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Mitoxantrone alone or in combination chemotherapy (VeMP) as second-line treatment in relapsed or refractory poor-prognosis non-Hodgkin's lymphoma. A report of the Non-Hodgkin's Lymphoma Co-operative Study Group (NHLCSG).
Santini G, Contu A, Porcellini A, Chisesi T, Coser P, Congiu AM, Morandi S, Manna A, Schintu GM, Quaini R, et al. Santini G, et al. Among authors: morandi s. Haematologica. 1991 Nov-Dec;76(6):485-90. Haematologica. 1991. PMID: 1820985 Clinical Trial.
Fractionated cyclophosphamide added to the IVAP regimen (idarubicin-vincristine-L-asparaginase-prednisone) could lower the risk of primary refractory disease in T-lineage but not B-lineage acute lymphoblastic leukemia: first results from a phase II clinical study.
Bassan R, Pogliani E, Lerede T, Fabris P, Rossi G, Morandi S, Casula P, Lambertenghi-Deliliers G, Vespignani M, Izzi T, Coser P, Corneo G, Barbui T. Bassan R, et al. Among authors: morandi s. Haematologica. 1999 Dec;84(12):1088-93. Haematologica. 1999. PMID: 10586210 Clinical Trial.
High rate of clinical and molecular remissions in follicular lymphoma patients receiving high-dose sequential chemotherapy and autografting at diagnosis: a multicenter, prospective study by the Gruppo Italiano Trapianto Midollo Osseo (GITMO).
Ladetto M, Corradini P, Vallet S, Benedetti F, Vitolo U, Martelli M, Brugiatelli M, Coser P, Perrotti A, Majolino I, Fioritoni G, Morandi S, Musso M, Zambello R, Chisesi T, Di Renzo N, Vivaldi P, De Crescenzo A, Gallamini A, Salvi F, Santini G, Boccomini C, Sorio M, Astolfi M, Drandi D, Pileri A, Tarella C. Ladetto M, et al. Among authors: morandi s. Blood. 2002 Sep 1;100(5):1559-65. doi: 10.1182/blood-2002-02-0621. Blood. 2002. PMID: 12176870 Free article. Clinical Trial.
Rhabdomyosarcoma presenting as acute leukemia.
Morandi S, Manna A, Sabattini E, Porcellini A. Morandi S, et al. J Pediatr Hematol Oncol. 1996 Aug;18(3):305-7. doi: 10.1097/00043426-199608000-00015. J Pediatr Hematol Oncol. 1996. PMID: 8689348
Risk-oriented postremission strategies in adult acute lymphoblastic leukemia: prospective confirmation of anthracycline activity in standard-risk class and role of hematopoietic stem cell transplants in high-risk groups.
Bassan R, Pogliani E, Casula P, Rossi G, Fabris P, Morandi S, Lambertenghi-Deliliers G, Vespignani M, Lerede T, Rambaldi A, Borleri G, Spedini P, Cortelezzi A, Izzi T, Coser P, Broccia G, Corneo G, Barbui T. Bassan R, et al. Among authors: morandi s. Hematol J. 2001;2(2):117-26. doi: 10.1038/sj/thj/6200091. Hematol J. 2001. PMID: 11424004 Clinical Trial.
Breast cancer or cutaneous lymphoma?
Spedini P, Morandi S. Spedini P, et al. Among authors: morandi s. Haematologica. 2000 Oct;85(10):1096. Haematologica. 2000. PMID: 11025604 No abstract available.
Cutaneous flagellate pigmentation by bleomycin.
Spedini P, Bergonzi C, Morandi S. Spedini P, et al. Among authors: morandi s. Haematologica. 2000 Aug;85(8):870. Haematologica. 2000. PMID: 10942936 No abstract available.
Role of early anthracycline dose-intensity according to expression of Philadelphia chromosome/BCR-ABL rearrangements in B-precursor adult acute lymphoblastic leukemia.
Bassan R, Rohatiner AZ, Lerede T, Di Bona E, Rambaldi A, Pogliani E, Rossi G, Fabris P, Morandi S, Casula P, Carter M, Lambertenghi-Deliliers G, Lister TA, Barbui T. Bassan R, et al. Among authors: morandi s. Hematol J. 2000;1(4):226-34. doi: 10.1038/sj.thj.6200032. Hematol J. 2000. PMID: 11920195
166 results